Literature DB >> 10681283

Fatal hyperammonemia after orthotopic lung transplantation.

G R Lichtenstein1, Y X Yang, F A Nunes, J D Lewis, M Tuchman, G Tino, L R Kaiser, H I Palevsky, R M Kotloff, E E Furth, J E Bavaria, M M Stecker, P Kaplan, G T Berry.   

Abstract

BACKGROUND: A case of fatal hyperammonemia complicating orthotopic lung transplantation was previously reported.
OBJECTIVE: To describe the incidence, clinical features, and treatment of hyperammonemia associated with orthotopic lung transplantation.
DESIGN: Retrospective cohort analysis.
SETTING: Academic medical center and lung transplantation center in Philadelphia, Pennsylvania. PATIENTS: 145 sequential adult patients who underwent orthotopic lung transplantation. MEASUREMENTS: Plasma ammonium levels.
RESULTS: Six of the 145 patients who had had orthotopic lung transplantation developed hyperammonemia, all within the first 26 days after transplantation. The 30-day post-transplantation mortality rate was 67% for patients with hyperammonemia compared with 17% for those without hyperammonemia (P = 0.01). Development of major gastrointestinal complications (P = 0.03), use of total parenteral nutrition (P < 0.001), and lung transplantation for primary pulmonary hypertension (P = 0.045) were associated with hyperammonemia.
CONCLUSIONS: Hyperammonemia is a potentially fatal event occurring after orthotopic lung transplantation. It is associated with high nitrogen load, concurrent medical stressors, primary pulmonary hypertension, and hepatic glutamine synthetase deficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681283     DOI: 10.7326/0003-4819-132-4-200002150-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Authors:  Ankit Bharat; Scott A Cunningham; G R Scott Budinger; Daniel Kreisel; Charl J DeWet; Andrew E Gelman; Ken Waites; Donna Crabb; Li Xiao; Sangeeta Bhorade; Namasivayam Ambalavanan; Daniel F Dilling; Erin M Lowery; Todd Astor; Ramsey Hachem; Alexander S Krupnick; Malcolm M DeCamp; Michael G Ison; Robin Patel
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

2.  Sequelae of Donor-derived Mollicutes Transmission in Lung Recipients.

Authors:  Ramiro Fernandez; Monica Chi; Michael G Ison; Ken B Waites; Donna M Crabb; Amy E Ratliff; Hector Cajigas; Malcolm M DeCamp; David Odell; G R Scott Budinger; Ankit Bharat
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

3.  Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model.

Authors:  X Wang; K E Greenwood-Quaintance; M J Karau; D R Block; J N Mandrekar; S A Cunningham; J M Mallea; R Patel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-28       Impact factor: 3.267

Review 4.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

5.  Acute hyperammonemic encephalopathy in adults: imaging findings.

Authors:  J M U-King-Im; E Yu; E Bartlett; R Soobrah; W Kucharczyk
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-18       Impact factor: 3.825

6.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 7.  Hyperammonemia in lung transplant patients and its management: a review.

Authors:  Akshay Kumar; Shailesh Advani; Kichloo Asim; Mohamed A Mohamed; Farah Wani; Jagmeet Singh; Michael Albosta; Nimisha Shiwalkar; Suresh Keshavamurthy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-14

Review 8.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

9.  Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.

Authors:  Xiaohui Wang; Melissa J Karau; Kerryl E Greenwood-Quaintance; Darci R Block; Jayawant N Mandrekar; Scott A Cunningham; Robin Patel
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

10.  Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.

Authors:  Ruby Upadhyay; Thomas P Bleck; Katharina M Busl
Journal:  Case Rep Med       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.